Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer
Serum carcinoembryonic antigen (CEA) is frequently monitored to detect colorectal cancer (CRC) recurrence after surgery. The clinical significance of transiently increased CEA during adjuvant chemotherapy is poorly understood. Serum CEA, CA19-9, CRP, YKL-40, and IL-6 were measured before, during, an...
Main Authors: | Kaisa Lehtomäki, Eetu Heervä, Pirkko-Liisa Kellokumpu-Lehtinen, Harri Mustonen, Tapio Salminen, Heikki Joensuu, Kethe Hermunen, Mogens Karsbøl Boisen, Julia Sidenius Johansen, Caj Haglund, Pia Osterlund |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/7/6753 |
Similar Items
-
Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer
by: Kaisa Lehtomäki, et al.
Published: (2021-08-01) -
YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer’s Disease
by: Ioannis Mavroudis, et al.
Published: (2021-12-01) -
YKL-40 and cytokines - a New Diagnostic Constellation in Rheumatoid Arthritis?
by: Kazakova Maria H., et al.
Published: (2017-03-01) -
YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
by: Maria Gevezova, et al.
Published: (2023-11-01) -
A novel biomarker in acute cholecystitis: YKL-40
by: Eray Çeliktürk, et al.
Published: (2023-04-01)